Table 3.
ROC curve for NOAF
| | AUC | 95% CI | p value | Cutoff | Sensitivity | Specificity |
|---|---|---|---|---|---|---|
| sST2, ng/mL | 0.785 | 0.723–0.848 | <0.001 | 31.59 | 0.768 | 0.713 |
| Base model | 0.718 | 0.650–0.786 | <0.001 | – | 0.643 | 0.742 |
| Base model + sST2 | 0.810 | 0.759–0.861 | <0.001 | – | 0.911 | 0.600 |
Base model included NT-proBNP, CRP, and LAD.
NOAF, new-onset atrial fibrillation; sST2, soluble suppression of tumorigenicity 2; ROC, receiver operating characteristic.